Skip to main content

Natera to Report its First Quarter 2024 Results on May 9

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information:


Natera’s First Quarter 2024 Financial Results


Thursday, May 9, 2024


1:30 p.m. PT (4:30 p.m. ET)

Live Dial-In:

1 (888) 770-7321 (Domestic)


1 (929) 201-7107 (International)

Conference ID:



A webcast replay will be available at

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit


Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709,

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc.,

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.